CeQur® Closes $100 Million Series E, Backed by Commercial Momentum and Growing Demand for CeQur Simplicity™
Series E Financing Reflects Sustained Investor Confidence in CeQur's Commercial Trajectory, Clinical Results, and Growing Demand for a Simpler Approach to Mealtime Insulin HORW, Switzerland, June 9, 2026 /PRNewswire/ -- CeQur, the company dedicated to simplifying mealtime insulin delivery...
Series E Financing Reflects Sustained Investor Confidence in CeQur's Commercial Trajectory, Clinical Results, and Growing Demand for a Simpler Approach to Mealtime Insulin HORW, Switzerland, June 9, 2026 /PRNewswire/ -- CeQur, the company dedicated to simplifying mealtime insulin delivery...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.